| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.03 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | NG-25 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |